SCHEMBL7605903

SCHEMBL7605903

COC(=O)Nc1ccc(C(CN[C@@H](CO)c2ccc(O)c(NS(=O)(=O)c3ccccc3)c2)c2ccc(NC(=O)OC)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.47
GFER P55789 2/20 0.47
APOBEC3G Q9HC16 1/20 0.47
KMT2A Q03164 4/20 0.45
LMNA P02545 3/20 0.45
MEN1 O00255 3/20 0.45
HTT P42858 2/20 0.45
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 2/20 0.43
ADRB3 P13945 13/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
POLB P06746 1/20 0.43
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
HPGD P15428 1/20 0.42
CRHBP P24387 1/20 0.42
CYP2C19 P33261 1/20 0.42
CRHR2 Q13324 1/20 0.42
NOD2 Q9HC29 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7607695 0.89 ADRB3 (0.52) ADRB3
SCHEMBL7613202 0.87 ADRB3 (0.55) GAAGFERKMT2ALMNAMEN1
SCHEMBL7612525 0.85 GAA (0.50) GAAGFERAPOBEC3GHTTALDH1A1
SCHEMBL7605897 0.84 ADRB3 (0.56) GAAGFERAPOBEC3GKMT2ALMNA
SCHEMBL7611056 0.82 ADRB3 (0.45) GAAGFERAPOBEC3GKMT2ALMNA
SCHEMBL7610374 0.82 ADRB2 (0.46) ADRB3SMN1; SMN2CYP3A4CYP2D6HPGD
SCHEMBL7611605 0.80 ADRB3 (0.56) GAAGFERAPOBEC3GADRB3
SCHEMBL7611045 0.78 ADRB3 (0.54) GAAGFERAPOBEC3GADRB3
SCHEMBL7605384 0.77 ADRB3 (0.51) GAAGFERAPOBEC3GKMT2ALMNA
SCHEMBL7605278 0.73 ADRB3 (0.55) ADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1230210-A1 AMINOALCOHOL DERIVATIVES USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-08-14 EP disclosed
WO-2001036375-A1 AMINOALCOHOL DERIVATIVES USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-05-25 WO disclosed